Open original FDA record ↗Recall record
- FDA identifier
- Z-0088-2010
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Oct 29, 2009
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Medtronic is in the process of updating the Enterra Therapy labeling to include information regarding the risks of bowel obstruction and/or perforation. Medtronic has received 15 reports since November 2002 of bowel obstruction and/or perforation of the bowel associated with Enterra Therapy System leads. Of the 15 reported events, 11 required surgical intervention (all patients recovered withou
Source facts
- Action
- Medtronic Neuromodulation issued a "Medical Device Correction" letter beginning August 25, 2009 addressed to Healthcare Professionals. The letter described the Nature of the Issue, Scope, Potential Severity of the Issue, Enterra Therapy System labeling updating information warnings, Recommendations and other Additional Information. For further information, contact Medronic Neuromodulation Technical Services at 1-800-707-0933.
- Initiated
- 2009-08-25
- Root cause
- Device Design
- Terminated
- 2012-05-22
- Distribution
- Worldwide Distribution.
- Recall number
- Z-0088-2010
- Recall status
- Terminated
- CDRH record ID
- 84612
- FDA classified
- 2009-10-29
- Recall event number
- 53086